News Focus
News Focus

H2R

Followers 45
Posts 2539
Boards Moderated 0
Alias Born 07/17/2014

H2R

Re: ccie1024 post# 747149

Monday, 02/03/2025 10:35:47 AM

Monday, February 03, 2025 10:35:47 AM

Post# of 821013
Is this a new hurdle?

I am a bit jaded when it comes to BP + RAs. This sentence, in particular, does not sit well with me:

Because these treatments are tailored to an individual’s tumour, they pose unique scientific questions on how they should be regulated.



nor does this one:

The Medicines and Healthcare products Regulatory Agency (MHRA) has today launched a consultation on regulatory guidance for individualised mRNA cancer immunotherapies (colloquially referred to as cancer vaccines).

Why mRNA specifically? What 'regulatory guidance'?

Or

The eight-week consultation was launched today and will run until 31 March 2025. The MHRA is asking all stakeholders, including developers of these medicines, to provide comments, after which the guidance will be updated.



I did not find much info on Julian Beach. His bio on MHRA is empty.

Is this yet another attempt to side line NWBO? I've been invested since 2013, I've seen all kinds of attacks on the Company. Maybe I'm reading too much into it.
I can't wait for the MHRA approval to put those behind us.

Best of luck to Patients, NWBO, and Longs!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News